U.S. Markets open in 1 hr 58 mins

Oil-Dri Corporation of America (ODC)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
22.98-1.00 (-4.17%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close23.98
Bid22.90 x 1000
Ask31.52 x 900
Day's Range22.80 - 23.98
52 Week Range22.80 - 38.05
Avg. Volume38,424
Market Cap170.385M
Beta (5Y Monthly)0.49
PE Ratio (TTM)22.42
EPS (TTM)1.02
Earnings DateMar 11, 2022
Forward Dividend & Yield1.08 (4.37%)
Ex-Dividend DateMay 12, 2022
1y Target EstN/A
  • GlobeNewswire

    Oil-Dri Announces Key Senior Leadership Promotions

    CHICAGO, May 20, 2022 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC) announced three key senior leadership promotions within the company. Effective today, Aaron Christiansen has been appointed to Vice President of Operations, Wade Robey to Vice President of Agriculture & Amlan Marketing, and Yasmith Bernal to Vice President, Crop & Horticulture and Innovation Center Site Lead. Daniel S. Jaffee, President and Chief Executive Officer, stated, “I would like to congratulate Aaron, Wa

  • Simply Wall St.

    Investors in Oil-Dri Corporation of America (NYSE:ODC) have unfortunately lost 29% over the last year

    Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...

  • GlobeNewswire

    Amlan International Launches Two New Natural Alternatives to Antibiotics for Poultry and Livestock

    Amlan has expanded its broad portfolio of animal health feed additives to include a natural alternative to anticoccidial drugs and vaccines and a natural pathogen control product for antibiotic-free production. Increasing demand for antibiotic-free production has created the need for solutions like Phylox® Feed and NeutraPath® that can reduce the negative health and production effects of enteric disease. The new products are commercially available in select international markets and can be used